Leishmaniasis Takes a Turn in HIV Patients: A Bolivian Case Study

A 34‑year‑old man living in the Bolivian Amazon region arrived at a clinic with a weakened immune system because of advanced HIV. He also had a localized form of cutaneous leishmaniasis. The skin lesions were confined to a small area at first.

Doctors tried the usual pentavalent antimonials, but the infection did not improve. Within weeks the disease spread, and the patient developed many ulcerated papules and nodules across his body. He also began to lose weight and experienced fever and night sweats.

Tests taken from the skin showed tiny parasites inside cells, confirming the presence of Leishmania amastigotes. A closer look under the microscope revealed the same organisms in tissue samples. The case was labeled as intermediate cutaneous leishmaniasis, now occurring alongside HIV.

The medical team switched to liposomal amphotericin B for a short course, then followed with oral miltefosine. The patient’s lesions shrank for a brief period, but the improvement faded quickly. The treatment plan could not keep the disease under control for long.

This story underlines how tricky it can be to diagnose and treat leishmaniasis when the immune system is already compromised. The range of skin manifestations can shift rapidly, so doctors must stay flexible in how they classify and manage the illness.